Can a simple protein infusion save kidneys in liver patients?
NCT ID NCT07270874
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two intravenous fluids—human albumin and saline—to see which better resolves acute kidney injury in people with decompensated cirrhosis. About 114 adults with moderate to severe kidney damage will receive either treatment. The goal is to improve kidney function without needing dialysis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AKI - ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Bringing the hospital home: a new model for End-Stage liver care
- A simple vein pressure reading may warn of kidney failure days earlier
- Could a poop pill protect the liver? trial tests fecal transplants against cirrhosis complications
- Can smarter antibiotic choices curb superbugs in liver disease?
- Smarter magnesium testing could shield Children's hearts and kidneys after surgery
- New study investigates hidden heart risk in liver patients